Congress has cut federal funding for public media — a $3.4 million loss for LAist. We count on readers like you to protect our nonprofit newsroom. Become a monthly member and sustain local journalism.
Steeply discounted overdose-reversal medicine now available to any Californian
California Gov. Gavin Newsom announced today that the state will sell Naloxone, the overdose-reversal medicine, to any resident at a steep discount. Here, a box of Narcan nasal spray sits at UC Berkeley student organization End Overdose’s table at Sproul Plaza on Jan. 23, 2024.
(
Juliana Yamada
/
CalMatters
)
Any Californian can purchase naloxone, an opioid overdose reversal medication, directly from the state at a discounted price, Gov. Gavin Newsom’s office announced Monday.
The medication is available online for $24 for a two-pack of the nasal spray, roughly half the market price of the drug. Previously, the discount was available only to government organizations and businesses.
“Life-saving medications shouldn’t come with a life-altering price tag. CalRx is about making essential drugs like naloxone affordable and accessible for all — not the privileged few,” Newsom said in a statement. CalRx is a Newsom initiative to bring down the cost of prescription drugs.
California has spent more than $1 billion fighting the opioid epidemic, which killed more than 8,900 people last year, according to preliminary data from the state health department. That represents a 13% increase in deaths from 2023.
Support for LAist comes from
The Naloxone Distribution Project and Access Initiative is part of the strategy to stop overdoses, which began spiking in 2019 as fentanyl, a highly potent synthetic opioid, infused the market. The rate of fentanyl-related overdose deaths began declining last year, according to state data.
More than 6 million naloxone kits have been distributed to local governments and organizations since 2018, according to state data. About 355,000 overdoses have been reversed.
In 2024, Newsom’s office announced a new supplier for the state initiative, Amneal Pharmaceuticals, which agreed to sell the steeply discounted drug to California. Days prior, Attorney General Rob Bonta announced a $273-million multistate settlement with the New Jersey-based company over its alleged failure to report suspicious opioid orders that contributed to the country’s epidemic.
“By getting this lower price, we are making the financial savings and able to use our dollars to buy more product, which of course is ultimately very much about saving lives,” said Elizabeth Landsberg, director of the Department of Health Care Access and Information, last year.
Naloxone is one of two current efforts by the state to make generic drugs more affordable under Newsom’s effort to lower the costs of pharmaceuticals. California has a $50-million contract to manufacture generic insulins for CalRx. That project is more than a year behind schedule.
Supported by the California Health Care Foundation (CHCF), which works to ensure that people have access to the care they need, when they need it, at a price they can afford. Visit www.chcf.org to learn more.
Support for LAist comes from
This article was originally published on CalMatters and was republished under the Creative Commons Attribution-NonCommercial-NoDerivatives license.
As Editor-in-Chief of our newsroom, I’m extremely proud of the work our top-notch journalists are doing here at LAist. We’re doing more hard-hitting watchdog journalism than ever before — powerful reporting on the economy, elections, climate and the homelessness crisis that is making a difference in your lives. At the same time, it’s never been more difficult to maintain a paywall-free, independent news source that informs, inspires, and engages everyone.
Simply put, we cannot do this essential work without your help. Federal funding for public media has been clawed back by Congress and that means LAist has lost $3.4 million in federal funding over the next two years. So we’re asking for your help. LAist has been there for you and we’re asking you to be here for us.
We rely on donations from readers like you to stay independent, which keeps our nonprofit newsroom strong and accountable to you.
No matter where you stand on the political spectrum, press freedom is at the core of keeping our nation free and fair. And as the landscape of free press changes, LAist will remain a voice you know and trust, but the amount of reader support we receive will help determine how strong of a newsroom we are going forward to cover the important news from our community.
Please take action today to support your trusted source for local news with a donation that makes sense for your budget.
Thank you for your generous support and believing in independent news.
Chip in now to fund your local journalism
(
LAist
)
Trending on LAist
-
Censorship has long been controversial. But lately, the issue of who does and doesn’t have the right to restrict kids’ access to books has been heating up across the country in the so-called culture wars. -
With less to prove than LA, the city is becoming a center of impressive culinary creativity.
-
Nearly 470 sections of guardrailing were stolen in the last fiscal year in L.A. and Ventura counties.
-
Monarch butterflies are on a path to extinction, but there is a way to support them — and maybe see them in your own yard — by planting milkweed.
-
With California voters facing a decision on redistricting this November, Surf City is poised to join the brewing battle over Congressional voting districts.
-
The drug dealer, the last of five defendants to plead guilty to federal charges linked to the 'Friends' actor’s death, will face a maximum sentence of 65 years in prison.
Best of LAist